Modeling Cardiovascular Diseases with hiPSC-Derived Cardiomyocytes in 2D and 3D Cultures

• Published in: International journal of molecular sciences Vol. 21; no. 9; p. 3404
• Main Authors: Sacchetto, Claudia, Vitiello, Libero, de Windt, Leon J, Rampazzo, Alessandra, Calore, Martina
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 11.05.2020; MDPI
• Subjects: 3D cardiac models; Bioengineering; cardiac disease modeling; Cardiomyocytes; Cardiomyopathy; Cardiovascular diseases; Cardiovascular Diseases - diagnosis; Cardiovascular Diseases - therapy; Cell culture; Cell Culture Techniques - methods; Cell Differentiation; Cells, Cultured; Coronary artery disease; CRISPR; Disease; Drug development; engineered heart tissue; Extracellular matrix; Genetic engineering; Genotype & phenotype; Heart; Heart diseases; human induced pluripotent stem cells; Human influences; Humans; Induced Pluripotent Stem Cells - cytology; Induced Pluripotent Stem Cells - physiology; Models, Cardiovascular; Morphology; Mutation; Myocytes, Cardiac - cytology; Myocytes, Cardiac - physiology; Patients; Pluripotency; Review; Stem cells; Structure-function relationships; Tissue Engineering - methods; Tissue Scaffolds; Two dimensional models; cardiac disease modeling; human induced pluripotent stem cells; engineered heart tissue; 3D cardiac models
• ISSN: 1422-0067; 1661-6596; 1422-0067
• DOI: 10.3390/ijms21093404

In the last decade, the generation of cardiac disease models based on human-induced pluripotent stem cells (hiPSCs) has become of common use, providing new opportunities to overcome the lack of appropriate cardiac models. Although much progress has been made toward the generation of hiPSC-derived cardiomyocytes (hiPS-CMs), several lines of evidence indicate that two-dimensional (2D) cell culturing presents significant limitations, including hiPS-CMs immaturity and the absence of interaction between different cell types and the extracellular matrix. More recently, new advances in bioengineering and co-culture systems have allowed the generation of three-dimensional (3D) constructs based on hiPSC-derived cells. Within these systems, biochemical and physical stimuli influence the maturation of hiPS-CMs, which can show structural and functional properties more similar to those present in adult cardiomyocytes. In this review, we describe the latest advances in 2D- and 3D-hiPSC technology for cardiac disease mechanisms investigation, drug development, and therapeutic studies.